Susan G. Komen for the Cure announces $58 million in grants
May 22, 2012
Susan G. Komen for the Cure recently announced its 2012 research program, which will provide 154 grants totaling $58 million. This year's research funding will cover the complete gamut of cancer care, according to Komen president Elizabeth Thompson. Specifically, the grants will support research in biomarkers for early detection, special populations and issues in metastatic and aggressive disease.
In addition to the research program, Komen also funds more than 500 active investigative grants and has allocated $8 million from this round of giving to its Promise Grants.
"None of this research or progress of the past 30 years would be possible without the generosity of our partners and donors in communities, and we are so grateful for those who understand and support all of our programs," said Nancy G. Brinker, founder and CEO of Komen. "Research has been a priority since 'day one.'"
One of the largest grants has been given to Wayne State University's Michelle Cote, Ph.D., for her study of special populations. Cote plans to research markers in African American women, who are particularly susceptible to developing the disease.
Researchers and universities that apply for grants from large nonprofit organizations could benefit from grant management software
to draft reports that demonstrate their funding needs.